Ehab Kasasbeh is a Cardiology physician affiliated with Vanderbilt University. OpenAlex indexes 19 publications with 386 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
113 Highway 70 East
Dickson, TN 370552075
Telephone
615-441-4435Provider last certified this registry record 10 Dec 2025.
Industry payments
48 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202517 payments
- Novartis Pharmaceuticals CorporationProgram year202520 payments
- PFIZER INC.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72%Beta blocker13.8%Carvedilol34%Metoprolol Succinate25%Metoprolol Tartrate23%Atenolol8%Nebivolol Hcl5%Sotalol3%Propranolol Hcl Er2%Part D<11 patientsStatin10.6%Atorvastatin Calcium54%Rosuvastatin Calcium28%Simvastatin10%Pravastatin Sodium5%Lovastatin3%Part D<11 patients+ 18 more classes in this area
Blood & clotting
22.1%Factor Xa inhibitor11.7%Eliquis85%Xarelto15%Part D≥96 patientsP2Y12 inhibitor8.8%Clopidogrel81%Prasugrel Hcl14%Brilinta5%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.4%SGLT2 inhibitor2.7%Farxiga83%Jardiance17%Part D<11 patientsPotassium supplement1.4%Potassium Chloride100%Part D≥20 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- How Can we Improve Non-Surgical Septal Reduction for Hypertrophic Obstructive Cardiomyopathy?
Journal of Cardiovascular Diseases & Diagnosis
2016 - Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary intervention
Journal of Thrombosis and Thrombolysis
2015 - Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure
Journal of the American Heart Association
2014
Similar KOLs
Other experts from the same institution or the same specialty.
James Crowe, MD
Vanderbilt University
Ingrid Mayer, MD
Vanderbilt University
Michael Debaun, MD
Vanderbilt University
Sam Chang, MD
Vanderbilt University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”